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Abstract. To investigate the question of whether lyric 
granules share a common biogenesis with lysosomes, 
cloned cytolytic T cell lines were derived from a pa- 
tient with I-cell disease. The targeting of two soluble 
lyric granule components, granzymes A and B, was 
studied in these cells which lack a functional 
mannose-6-phosphate (Man-6-P) receptor-mediated 
pathway to lysosomes. Using antibodies and enzymatic 
substrates to detect the lytic proteins, I-cells were 
found to constitutively secrete granzymes A  and B in 
contrast to normal cells in which these proteins were 
stored for regulated secretion. These results suggest 
that granzymes A and B are normally targeted to the 
lytie granules of activated lymphocytes by the Man-6- 
P  receptor. 
In normal cells, the grartzymes bear Man-6-P 
residues, since the oligosaccharide side chains of gran- 
zymes A and B, as well as radioactive phosphate on 
granzyme A from labeled cells, were removed by en- 
doglycosidase H  (Endo H). However, in I-ceils, gran- 
zymes cannot bear Man-6-P and granzyme B acquires 
complex glycans, becoming Endo H  resistant. 
Although the levels of granzymes A and B in cyto- 
lytic I-cell lymphocytes are <30%  of the normal lev- 
els, immunolocalization and cell fractionation of gran- 
zyme A demonstrated that this reduced amount is 
correctly localized in the lytic granules. Therefore, a 
Man-6-P receptor~'ndependent pathway to the lytic 
granules must also exist. Cathepsin B colocalizes with 
granzyme A in both normal and I-cells indicating that 
lysosomal proteins can also use the Man-6-P recep- 
tor-independent pathway in these cells. The complete 
overlap of these lysosomal and lytic markers implies 
that the lytic granules perform both lysosomal and 
secretory roles in cytolytic lymphocytes. The secre- 
tory role of lytic granules formed by the Man-6-P 
receptor-independent pathway is intact as assessed by 
the ability of I-cell lymphocytes to lyse target cells by 
regulated secretion. 
YTIC granules of  cytotoxic  lymphocytes  and natural killer 
cells are specialized secretory organelles containing 
a unique set of  proteins involved in cell-mediated  kill- 
ing. These granules provide a mechanism of directed regu- 
lated  secretion in  response  to  a  signal  generated upon 
specific recognition of the target by the cytotoxic cell. Upon 
recognition,  the granules reorient within the cell and move 
towards the point of  contact where they fuse with the plasma 
membrane and release their contents. This event results in 
the destruction of the target cell. The granules contain a 
small number of proteins which appear to be involved in the 
destruction process. The major components of  the lyric gran- 
ules are proteoglycans, a number of serine proteases termed 
granzymes of which three have been identified in human 
lymphocytes and eight in mouse lymphocytes, and the lyric 
protein perforin  (for  review  see Tschopp  and  Nabholz, 
1990).  These granules contain all of the components re- 
quired for killing and isolated granules are able to cause tar- 
get cell lysis in vitro (Henkart et al.,  1984; Podack and 
Konigsberg,  1984). Exactly how these proteins  are selec- 
tively  sorted and packaged into the lyric granules is not 
knov:n. 
Several recent studies have suggested that the lyric gran- 
ules are closely related to lysosomes and that the two or- 
ganelles  may share a  common biogenesis.  A  number of 
lysosomal enzymes have been colocalized with perforin and 
granzymes in the lyric granules in human, mouse, and rat 
cells,  and  the  cation-independent  mannose-6-phosphate 
(Man-6-P) 1 receptor has  been identified  in  some of the 
granules (Burkhardt et al., 1990; Peters et al., 1991). Fur- 
thermore, lytic granules have  been identified  as slightly 
acidic organeUes with a pH of 5.5, comparable to that of  the 
prelysosomal compartment (Burkhardt et al., 1990; Masson 
et al., 1990). Furthermore, the uptake of  exogenous proteins 
has demonstrated that the lyric granules,  like lysosomal 
compartments,  can be reached by the endocytic pathway 
(Burkhardt  et al.,  1990). These observations  demonstrate 
that lyric  granules are endocytic compai~iaaients and may 
share a common biogenesis with lysosomes. 
In a rat natural killer cell line it has been demonstrated that 
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suggesting that this protein might use the Man-6-P receptor 
pathway to be sorted to the cytolytic granules ~urkhardt et 
al., 1989). Direct functional evidence for this sorting mecha- 
nism in the formarion of lytic granules is lacking. To examine 
this possibility,  cloned cytotoxic T cell lines from a patient 
with I-cell disease (mucolipidosis 1I) were derived.  These 
patients exhibit  a generic  autosomal defect for the enzyme 
(N-acetylglucosaminyl-phosphotransferase)  responsible  for 
the phosphorylarion of mannose which occurs on some gly- 
coproteins in the cis-Golgi compartment and results in the 
formation of Man-6-P oligosaccharide (Kornfeld and Korn- 
feld, 1985; von Figura and Hasilik, 1986). As a consequence 
of the I-cell defect,  soluble lysosomal proteins are not phos- 
phorylated and cannot be recognized by the Man-6-P recep- 
tor  which  would normally  sort them into  the lysosomal 
pathway. 
Previous studies have  demonstrated  the absence of the 
phosphotransferase in various cell types including lymphoid 
tissues of I-cell patients (Haubeck et al.,  1985; Little et al., 
1987; Waheed et al.,  1982). However, lymphocytes as well 
as hepatocytes and Kuptfer cells are exceptional in I-cell dis- 
ease patients in showing nearly normal levels of lysosomal 
enzymes (Glaser  et al.,  1974;  Owada and Neufeld,  1982; 
Waheed et al., 1982), and it has been suggested that an alter- 
native  pathway exists for the delivery of proteins  to lyso- 
somes in these cell types. Studies using B and natural killer 
cell lines dearly demonstrate that the I-cell defect is present 
in these cell types either by increased secretion of lysosomal 
enzymes or by the absence of Man-6-P on these enzymes 
(Haubeck et al.,  1985; Little et al.,  1987).  Consequently, 
Man-6-P  receptor-dependent  delivery  of  lysosomal  en- 
zymes should be defective  in such cells. 
By deriving T cell lines from a patient with I-cell disease, 
it was possible to test the hypothesis that the soluble lyric 
granule proteins granzymes A and B, like soluble lysosomal 
enzymes, might also require the Man-6-P modification  for 
correct  sorting to the lyric granules.  These studies suggest 
that granzymes A  and B  are normally sorted to the lyric 
granules  via the Man-6-P pathway, but that an alternative 
Man-6-P receptor-independent pathway to the lytic granules 
also exists. 
Materials and Methods 
Antisera 
Antibodies against human granzyme A were raised by immunizing NZW 
rabbits with lyric granules from the dense fraction obtained after Percoll 
fractionation of activated human cytolytic clones as described below. Rab- 
bits were primed with 0.5  mg of immunogen,  emulsified  in complete 
Freund's adjuvant, and boosted 2 and 5 wk after the initial priming with 0.5 
nag immunogen emulsified  in incomplete Freund's adjuvant.  One rabbit 
responded with an antiserum that specifically recognized human granzyme 
A by immunostalulng and irmnunoblotting. 
Antibodies against recombinant  human granzyme B ~ere provided by J. 
Tschopp and  prepared as  previously  described  (Masson and Tschopp, 
1987). Anti-human  eathepsin B was purchased from The Binding Site, Bir- 
mingham, U.K.,  as a  sheep antiserum and biotinylated using standard 
procedures (Harlow and Lane, 1988) for use in double-labeling immuno- 
staining. 
All second-stage  antibodies were purchased from Southern Biotechnol- 
ogy, Birmingham, AL. These were goat anti-mouse and goat anti-rabbit 
IgG conjugated to either Texas red or fluorescein as described for immuno- 
staining or goat anti-mouse kappa fight chain coupled to horseradish perox- 
idase in the case of immunoblotting using chemiluminescence. 
Radioactive  second-stage  antibodies labeled with z25I were purchased 
from Amersham Intl., Buckinghamshire, U.K. 
Cell Culture 
Human T cell clones were maintained in RPMI, 100 U/ml rlL-2, 5% hu- 
man serum. T cell clones were derived essentially as previously described 
(Lanzavecchia,  1985). Peripheral blood lymphocytes  from a patient diag- 
nosed with I-cell disease were isolated.  The clinical diagnosis of this patient 
indicated increased serum levels of the following lysosomal enzymes (nor- 
mal control values  in parentheses): /~-hexosaminidase 208 mU/mg (14), 
arylsulfatase  5.9  mU/mg (0.3),  ~N-acetylglucosaminidase 0.45  mU/mg 
(0.16),  and/3-galactosidase 0.43  mU/mg (0.4).  The enzyme levels  from 
fibroblast cell lysates derived from the same patient were correspondingly 
decreased compared with normal controls (in parentheses): fl-hexosamini- 
dase 22 mU/mg (215), arylsulfatase  A 1.1 mU/mg (13.5), and B-glucuron- 
idase 0.4 mU/mg (2.2). Lymphocytes  were purified over Histopaque 1077 
(Sigma Immunochemicals, St.  Louis, MO) and plated at 106/rnl with ir- 
radiated allogeneic lymphoeytes at the same concentration in RPMI medium 
containing 5% human serum (Red Cross, Switzerland), t00 U/ml of rlL-2 
(Hoffmann-La Roche, Nutley, NJ), and 1 ~g/ml phytohem-agglutinin  (Bur- 
roughs Wellcome,  Dartford, U.K.). After expansion, cells were sorted by 
FACS  |  after staining with anti-CD4 or anti-CD8 antibodies (Becton-Dickin- 
son Immunocytometry Sys.,  Mountain View, CA) and cloned at 0.2 cells 
per well. All cells used in this study were CD8  + cells. Normal T cell clones 
were  a gift from A.  Lanzavecchia  and were generated in the same way 
(Lanzavecchia,  1985). 
Enzymatic Assays 
Glucosaminidase was assayed as described (Scalera et al.,  1980). Briefly, 
samples were diluted to 200/~1 in 200 mM citric acid, pH 4.5, 0.2% Triton 
X-100, and incubated in the presence of 8 mM p-nitrophenyl N-acetyl-~q>- 
glucosaminide (Sigma Chem. Co.) for 30 min at 370C. The reaction was 
stopped by the addition of 1 ml 67 mM NaCI, 83 mM Na2CO3, 33 mM 
glycine,  pH 10.5, and the absorbance read at 405 nm. 
Enzymatic assays for granzymes A and B were carried out as previously 
described (Odake et al.,  1991; Pasternack et al.,  1986). Granzyme A was 
assayed by addition of 180/~1 of 0.2 M  Tris-HC1,  pH 8.1, 2  x  10  "q M 
N-benzyloxy-carbonyl-L-lysine-thiobenzylester  (BLT), 2.2  x  10  -4 M 5,5'- 
dithio-bis(2-nitrobenzoic acid) to 20/~1 of lysate (0.1 M Tris HC1, pH 8, 
0.1% Triton X-100). The absorbance at 405 nm was read over 30 rain at 
37~  on a microplate reader (Molecular Devices Corp., Menlo Park, CA). 
Protein concentrations from total cell lysates prepared as described below 
were determined using the protein assay and specific activities calculated 
from the rate of this reaction and this value (Bio Pad Labs., Hercules,  CA). 
1 U  is defined  as the amount of enzyme activity required to produce a 
change in absorbance at 405 nm of 10D at 37~ 
Granzyme B was asswyed  using essentiaUy the same procedure, the sub- 
strate being 0.1  mM Boc-Ala-Ala-Asp-thiobenzylester  in 0.3  mM  5,5'- 
dithio-bis(2-m'tr~nzoic acid), 1 mM EDTA, 0.05% Triton X-100. 100 #1 
of lysate was mixed with 100/~1 substrate and the rate of change of absor- 
bance at 405 nm determined using the kinetic plate reader. 
For each time point cell lysates from two independently derived clones 
were assayed for activity. For the normal cell lysates these clones were de- 
rived from t~  separate individuals.  All I-cell clones were derived from a 
single individual, but 2-4 independently isolated  CD8  + clones derived 
from this individual were tested for each time point shown. 
Glycosidase Treatments 
Total cell lysates were prepared by washing cells three times in PBS, resus- 
pending at 107/ml in 0.1 M "iris, pH 8, 0.1% Triton X-100, vortexing,  and 
lysing on ice for 30 rain. Lysates were then centrifuged in a microfuge at 
4~  for 15 min and the soluble fraction stored at -20~  before further 
analysis. 
Samples in 0.1% Triton X-tO0  treated with peptide-N-glycosidase  F 
(PNGase F) (Boehringer Mannheim, Germany) were first denatured in 
0.5% SDS at 95~  for 5 win, the SDS was quenched by addition of  a twofold 
excess of nonionic detergent, and the enzyme was added for 12-16 h at 
370C. Samples  treated with endoglycosidase  H (Endo H) were incubated 
at 37~  for 12-16 h in 9 mM CaC12 and 50 mM sodium acetate, pH 5.5, 
in the presence of 1 mM PMSF. 
Metabolic Labeling and Immunoprecipitation 
Normal T cells were labeled with [32P]orthophosphate (>1,000 Ci/mmol, 
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1-2  x  t07/ml  and  0.5  mCi  [aZP]orthophosphate/mt in phosphate-free 
medium, or 250/~Ci/ml [35S]methioninc in methionine-free medium, both 
containing  10% dialyzed FCS and 100 U/nil rIL-2. The ceil pellet was lysed 
in 1 ml of 150 mM NaCI, 50ram Tris-HCl, pH 8, 1 mM MgCI2, 2% NP- 
40, and 0,1 mM PMSF for 30 rain on ice and precleared by incubation with 
10 #1  normal  rabbit  serum,  and  then protein  A~Sepharnse (Pharmacia, 
Uppsala, Sweden) each for 30 vain. Granzyme A was precipitated with rab- 
bit antiserum overnight and then for 30 rain with protein A-Sepharose.  A 
preimmune  serum from the same rabbit was used as a negative control. 
Precipitates were washed six times with PBS, 0.1% NP-40 and etuted in 20 
mM Tris, pH 7, 0.5 % SDS at 95~  All precipitations and washes were car- 
fled out at 4"C. For Endo H treatment, both untreated and treated samples 
were adjusted to t% NP-40, 0.t mM PMSF and incubated at 37~  either 
with or without the addition of  Endo H for 4-5 h. Samples were electropho- 
resed on a 10% polyacryIamide gel under reducing conditions as described 
below. 
Electrophoresis  and Immunoblotting 
SDS-PAGE was carried out in 10% acrylamide gels under nonreducing con- 
ditions.  12%  nonreducing  acrylamide  gels  were  used  for glycosidase- 
treated  samples.  Gels were transferred  to nitrocellulose  (Sehleicher  & 
Schnell, Inc., Germany) using the Trans-Biot apparatus in 25 mM Tris, 192 
mM glycine,  20% methanol,  pH 8.3 0Bio Pad Labs).  Filters were then 
probed using either radioactive or chemiluminescent antibody detection as 
indicated. Filters were blocked for 2 h in 1% casein, 150 mM NaC1, 50 mM 
Tris-HCt, pH 8, 0.1% sodium azide. The primary antibody was diluted in 
casein buffer  and  incubated  2-16 h  at room temperature.  Filters were 
washed twice in PBS for 5 rain, arm incubated with t~I-labeted anti-rabbit 
antibody  at t0  ~ ctm~/ml for t  h. Filters were then washed thr~e times in 
PBS for 10 min each. blotted dry, covered with cellophane film. and ex- 
posed using an intensifying screen and XAR-5 photographic film (Eastman 
Kodak, Rochester. NY) at -70~  for 12-72 h. For chemiluminescent detec- 
tion the procedure was essentially the same except that the blocking buffer 
contained 5% nonfat dried milk, the wash buffer was PBS, 0.1% Tween 20, 
and  a horseradish  peroxidase-labeted  anti-Ig second  antibody  was used 
(Southern  Biotechnology or Amersham  Intl.). Filters were developed for 
1 rain in chemiluminescent  detection re~gents (Amersbam Intl.), and ex- 
posed  for times varying between  15 s and 5 rain using Hyperfilm ECL 
(Amersham  Intl.). 
Transfection 
Transiem transfections were carried out using DEAE-Dextran as previously 
described (Guan and Rose, 1984). Briefly, COS-7 calls were plated at 6-7 
x  I0  s per tOO-ram dish and transfected the following day with 10 #g of 
DNA in pSRaSD7 (kindly provided by Dan Denney, Stanford University) 
in 10 mM Tris-HC1, 150 ram NaCI, pH 7.4, containing 500 ~g/mt DEAE- 
Dextran  (Pharmacia).  This vector contains the SRo~ promoter  (Takehe et 
al.,  1988), and is otherwise based on the eDNA expression vector previ- 
ously described (Okayama and Berg, 1983). After 30 rain at 37"C, the DNA 
solution was replaced with medium containing  100 ~m chloroquine. Cells 
were incubated an additional 3 h before the medium was replaced with nor- 
real culture medium (Dulbocco's MEM, 10% FCS). Cells were assayed by 
irnmunostainlng  after 2 d. 
Immunofluorescence 
Cells were adhered  to glass  slides  coated  with 50 #g/ml poly-L-tysine 
(Sigma Immunochemicats),  fixed in 2 % paraformaidehyde  (Polyscience, 
Nilns,  IL) in PBS for 45 rain at room temperature,  and quenched in three 
changes  of 50 mM ammonium chloride.  Cells were permeabilized  for 
20-30 rain in dilution buffer (PBS, 0,01% saponin, 0.25% gelatin) contain- 
hag 0,1% NP.40, rinsed in dilution buffer, and stained with the primary anti- 
body in dilution buffer for 30-45 rain. After extensive washing in dilution 
buffer, cells were stained with fluorescant conjugated second antibodies for 
30-45  rain,  washed extensively in dilution  buffer, and then PBS before 
mounting  in 90%  glycerol/PBS  containing  2.5%  DABCO 04-Diazabi- 
cyr  (Fluka Chemie AG, Buchs, Switzerland) antibleaching 
reagent.  Cells were stained  with antisera  at a  1:I00  dilution  for anti- 
granzyme A and a 1:50 dilution for biotinylated sheep anti-human catbep- 
sin B antisera (The Binding Site),  followed by a 1:100 dilution of a stock 
solution of  either anti-rabbit FFI3C  or streptavidin-Texas red (Southern Bio- 
technology),  respectively. Appropriate  controls without first stage or with 
the rabbit preimmune serum at the same dilution were always included. ALl 
samples were examined using the MRC 600 confocai mi~ (BioRad 
Labs). When comparisons were made between cell types and for negative 
control samples, care was taken to use the exact same settings of the micro- 
scope for the laser intensity and confocM detection. 
Cell Fractionation 
l~picaUy 5  x  107-10  s cells were ffactionated.  Cells were washed three 
times in PBS and once in 50 mM Hepes, pH 7.2, 90 mM KC1. Cells were 
resnspended in a minimum of 6 ml of Hepes/KC1 or fivefold the volume of 
the pellet, whichever was greater. Cells were disrupted at 4~  by passing 
them through the ball bearing cell homogenizer (Balch and Rothman, 1985) 
20 times using a bali bearing of 8.006 mm diam.  Lysis was verified under 
the microscope when the lysis buffer appeared grainy owing to the presence 
of organdies. Nuclear material was spun out at 900 g (2,100 rpm in a Her- 
aeus Sepatech centrifuge) for 4 rain at 4~C. The pellet was washed once in 
4 ml Hepes/KCl buffer and added to the soluble fr~:fion  to make a final 
volume of 10 nil. Using a stock of 90 ml Percoll (Pharmacia)  with l0 ml 
500 rnM Hepes, pH 7.2, 900 mM KCI, a Percoll step gradient was formed 
by underlaying 15.9 m139% Percolt with 12.1 m190% Percoll. All dilutions 
of Percoll were made in 50 mM Hepes, pH 7.2, 90 mM KCt. The soluble 
cell lysate was then overlayed onto this gradient and centrifuged at 40,000 
g (15,000 rpm using a TST 28.38 Kontron rotor) for 30 rain at 4"C. The 
top 10 ml of soluble lysate that did not enter the gradient was removed and 
discarded,  and l-ml fractions were collected from the top of the gradient. 
Samples of each fraction were assayed for granzyme  A activity:  35 #I of 
a l:10 dilution of each fraction were added to 200 #1 of 1 mM BLT, 1 mM 
5,5'Mithio-bis(2-nitrobenzoic acid) in 300 mM Tris, pH 8.1, and the absor- 
bance at 405 nm was read after 20 min. For fractions used for immuniza- 
tion, granules were lysed by addition of NaCl to 1.5 M, and Percolt was 
removed by centrifngatioa  at 200,000 g (45,000 rpm in the SWSOA rotor) 
for 2.5 h at 4~C. The granule fractions were then stored at -20~ 
Cell Cytotoxicity 
Cytotoxicity of T cells was determined at 14 d after stimulation using anti- 
CD3 antibody bound via the Fc receptor  of target cells as previously de- 
scribed (Lanzavecchia et al., 1988). Target cells were coated with anti-CD3 
antibody by addition of  purified antibody at I #g/ml immediately before ad- 
dition.  Since only the target cells express the Fc receptor, only these cells 
become coated with antibody. The antibody is directed against an invariant 
component of the T cell receptor complex which is able to recognize and 
activate T cells (Lanzavecchia et al., 1988). Briefly, varying ratios of stimu- 
lated cells were added to 104 5tCr-labeled P815 target cells in a final eel- 
tune of 200/d RPMI, 10% FCS at 37~  for 4 h. Plates were spun gently 
at 1.000 rpm for 5 rain and t00 g.l aiiquots counted using a gamma counter. 
The percentage  of specific target  lysis  was calculated  as equal to (ex- 
perimental release -  spontaneous release)/(totai release -  spontaneous re- 
lease).  Spomaneous release was <10%o 
Results 
1-CeU Lymphocytes Contain Reduced Levels 
of Granzymes 
The cell lines derived were first analyzed  for the presence 
of N-acetyl-B-o-glucosamirddase,  a typical soluble lysosomal 
enzyme.  Lysates  from four different clones were assayed. 
I-cell lines were found to contain reduced levels of glucos- 
aminidase activity (9.8  mU/mg,  standard error 0.9) com- 
pared with normal ceil lines (27.2 mU/mg, standard error 
2.9), Granzymes are serine proteases with well-defined  sub- 
strate specificities  (Odake  et al.,  1991).  To determine  the 
amount of these proteins present in normal and I-cell clones, 
chromogenic substrates were used to measure the specific 
activities of these enzymes in cell lysates. The specific activi- 
ties of granzyme A and B vary at different time points after 
T  cell  stimulation  during which period the cells  are syn- 
thesizing the lyric granule components (Podack and Kupfer, 
1991). In normal T cells, granzyme A activity increases with 
time after stimulation from 50 mU/mg at day 6 after stimula- 
tion to 150 mU/mg at day 14 after stimulation.  In the I-cell 
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Figure 1. The specific activities of granzymes A and B at different 
times after stimulation. Black bars represent values from normal 
cells;  white  bars,  values from I-cells.  Standard  error bars  are 
shown. 
clones, the level of granzyme A is much lower at all three 
time points analyzed and only increases from 18 mU/mg at 
day 6 after stimulation to 30 mU/mg at day 14 (Fig.  1). For 
granzyme B the specific activity varied only between 12 and 
27 mU/mg at the three different time points. In I-cells the 
level of granzyme B seems to decrease with time after stimu- 
lation, from a level of 25 mU/mg, equivalent to that of the 
normal cells at day 6 after stimulation, to a level of only 2 
mU/mg well below that of the normal cells at day 14 (Fig. 
1). This assay, using the synthetic substrate for granzyme B, 
is both less sensitive and more variable than the assay for 
granzyme A  using the synthetic substrate BLT.  However, 
with both substrates it is clear that by 14 d after stimulation, 
when cells are effective killers,  the 1-cells  contain signifi- 
cantly lower levels of both granzymes A and B than the nor- 
mal cells. This suggests either that the I-cells produce lower 
levels of the  granzymes or  that  these  proteins  are  being 
secreted from the cell rather than correctly packaged and 
stored. 
1-CeU Cytotoxic Lymphocytes Secrete 
Granzymes Constitutively 
To distinguish whether the reduced levels of  granzyme A and 
Figure 2. Immunoblot of nor- 
mal and I-cell lysates (L) and 
supematants  (M)  with  anti- 
granzyme  A  antiserum,  and 
chemiluminescent  detection. 
Both normal and I-cells were 
lysed at 107 cells/ml and 100 
~1 of  lysate was loaded in each 
lane. Supematants were taken 
from equal numbers of cells 
grown in media between days 
5 and 7 after stimulation. Ar- 
rowheads  mark  the  relative 
positions  of molecular  mass 
markers (kD). 
B in the I-cells were due to a reduced biosynthesis or secre- 
tion from the cell, the culture media from the T cell clones 
were examined for the presence of granzyme A and B by im- 
munoblotting. To avoid possible contamination from the ini- 
tial target cell destruction in the first 2-3 d after stimulation, 
cells  were cultured  for at  least  5-10  d  after stimulation, 
washed,  and resuspended in new culture medium without 
target cells. The cells were then cultured for two additional 
days before the supernatant was collected, and cells from the 
same culture were washed and lysed using 0.1% Triton X-100 
for analysis. Fig. 2  shows that I-cells secrete granzyme A, 
whereas normal cells do not. Granzyme A is a 27-kD mono- 
mer which forms a homodimer with an apparent molecular 
mass  of 50 kD  (Harneed et al.,  1988;  Krahenbuhl et at., 
1988).  Virtually  all  of  the  granzyme  A  is  found  as  a 
homodimer in  normal cell lysates,  and only a  faint band 
represents the monomeric granzyme A. Granzyme A is not 
detectable in  the  supernatant  of normal  cells  as  either a 
monomer or a  dimer. Loading an equal number of I-cells 
(equivalent to  106 cells), the granzyme A  dimer is barely 
visible in the I-cell lysate. In contrast, both the monomer and 
dimer forms of granzyme A are clearly present in the culture 
media of I-cells. This demonstrates that while granzyme A 
is retained as a  dimer in normal cells,  it is constitutively 
secreted from I-cells as both monomer and dimer. It should 
be noted that in  other experiments (not shown) using  in- 
creased amounts of I-cell lysate, a faint band corresponding 
to the granzyme A dimer could be detected by immunoblot- 
ring. This is consistent with the data from Fig.  1 in which 
granzyme A activity can be detected by the more sensitive 
enzymatic assay. 
Fig.  3  shows  a  similar immunoblot using  an antiserum 
which detects granzyme B. Granzyme B is detected as a 32- 
kD band in the normal cell lysate, but is not detectable in 
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mal (N) and I-cell (I)) cell ly- 
sates and culture media from 
days 10-12 after cell stimula- 
tion  and  the  medium  alone 
(-) with anti-granzyme B an- 
tiserum and radioactive detec- 
tion.  Lysates  were  prepared 
from cells grown for 12 d after 
restimulation.  The  culture 
media  were  harvested  from 
equal numbers of cells grown 
at the same concentration be- 
tween  days  10  and  12  after 
restimulation.  An  additional 
lane containing  only the cul- 
ture  medium  was  run  as  a 
negative  control  for possible 
background  derived from the 
serum. Arrowheads mark the 
relative positions of  molecular 
mass markers (kD). 
Figure 4.  Immunoblot  show- 
ing  PNGase  F  treatment  of 
normal and I-cell lysates im- 
munoblotted  and  detected 
with anti-granzyme B and ra- 
dioactive  detection.  Each 
sample was digested with two 
different concentrations of en- 
zyme  to  ensure  complete 
digestion.  Arrowheads  mark 
the  relative  positions  of mo- 
lecular mass markers (kD). 
H-sensitive component in the I-cell granzyme B is important 
as this demonstrates that the phosphotransferase defect in 
these I-cell lines is complete, since any granzyme B undergo- 
ing  phosphorylation would  result in  an  Endo-H  sensitive 
form. 
the cell medium. However, in the I-cells the major band de- 
tected is a 35-kD form which is present in both the cell lysate 
and in the cell medium. This suggests that, in I-cells, gran- 
zyme B is constitutively secreted from the cells, in contrast 
to normal cells in which this protein is stored for regulated 
secretion. The fact that granzyme B migrates with an appar- 
ently higher molecular mass of 35-kD in I-cells compared 
with  normal  cells  suggests  that  this  protein  is  differently 
processed in the two cell types. Lower molecular mass forms 
of 32-kD and 30-kD are also detected in the I-cell lysate, 
consistent with the three forms representing different stages 
of glycosylation.  It is the  highest molecular mass,  35-kD 
form which is constitutively secreted from the I-cells. 
To understand the basis for these size differences, glycosi- 
dase treatments were used to investigate the processing of 
granzyme B  in  normal  and  I-cells.  PNGase  F  digestion, 
which  cleaves  all  sugar  moieties  from  the  granzyme  B, 
demonstrates that the higher molecular mass form of gran- 
zyme B is the result of the different processing of this protein 
in these cells (Fig. 4).  After PNGase F  digestion, all three 
bands detected in the I-cell lysate are reduced to a  single 
band of 27 kD, as is the 32-kD band found in the normal cell 
lysate. This confirms that the 30-, 32-, and 35-kD forms rep- 
resent three different glycosylation states of the same protein. 
An important point is that the carbohydrate on granzyme 
B is sensitive to digestion with Endo H  in normal cells, but 
resistant in I-cells (Fig. 5). The 27-kD form found in normal 
cells is Endo H  sensitive, which is consistent with the con- 
cept that addition of Man-6-P in the cis-Golgi compartments 
prevents  further  glycosylation of these  side  chains  in  the 
medial and trans-Golgi compartments (yon Figura and Hasi- 
lik,  1986).  Consequently,  the phosphorylated oligosaccha- 
ride  side-chains  of granzyme B  remain as  high  mannose 
residues which are sensitive to Endo H  digestion.  In con- 
trast, the 30-kD, 32-kD, and 35-kD forms found in I-cells are 
all  unaffected by Endo  H  treatment.  This  shows  that  the 
oligosaccharide  side  chains  of granzyme B  are  not phos- 
phorylated in the cis-Golgi comparanent of I-cells, but are 
modified to become complex glycans, which are resistant to 
Endo H. The fact that it is not possible to detect any Endo 
Granzyme A  Bears Man-6-P Residues in 
Normal Lymphocytes 
The data obtained from the I-cells suggests that granzymes 
A and B are normally targeted to the granules by the Man-6- 
P  receptor. This predicts that in normal cells granzymes A 
and B must bear Man-6-P residues in their side chains.  To 
confirm this biochemieaUy, granzyme A was immunoprecip- 
itated from cells labeled with radioactive phosphate. Fig. 6 
a shows a normal T cell clone labeled at 6 d after stimulation 
with inorganic [32p]orthophosphate and precipitated with a 
rabbit antiserum to granzyme A.  The immune serum (but 
not the preimmune serum) precipitates a phosphate-labeled 
band of 30 kD under reducing conditions corresponding to 
the granzyme A  monomer. Endo H  treatment removes the 
oligosaccharide side chain containing the radioactive phos- 
phate and the granzyme A monomer can no longer be seen. 
That this is not due to degradation of the granzyme A by ad- 
dition of Endo H is confirmed by an identical Endo H treat- 
ment of granzyme A immunoprecipitated from cells labeled 
with  [35S]methionine  (Fig.  6  b):  in these samples Endo  H 
treatment results in a decrease in molecular mass from 30 
Figure 5.  Immunoblot show- 
ing Endo H digestion of gran- 
zyme B in cell lysates of nor- 
mal and I-cells. Lysates were 
digested in two different con- 
centrations  of enzyme to en- 
sure complete digestion.  The 
control  samples  (-)  were 
treated identically except that 
no  enzyme was  added.  Ar- 
rowheads  mark  the  relative 
positions  of molecular  mass 
markers (kD). 
Grifftths and Isaaz Man-6-P Receptor Targeting of Granzymes  889 Figure 6. (a) Autoradiograph of 32P-labeled T cell clone, precipi- 
tated with an antiserum against granzyme A or the preimmune se- 
rum and run under reducing conditions. Precipitates were either 
treated (+) or untreated (-) with Endo H. Each lane represents a 
precipitate  from  5  ￿  10  ~ labeled  cells.  (b)  [35S]Methionine- 
labeled T cell clone precipitated and Endo H treated as above. Ar- 
rowheads mark the relative positions of molecular mass markers 
Oct)). 
to 27 kD, consistent with the loss of high mannose sugars, 
but with no loss of  intensity  of  the immunoprecipitated band. 
Together these results  confirm that,  in normal cells,  the 
oligosaccharide side chains of  granzyme  A are high mannose 
and furthermore bear a phosphate addition. 
A  Man-6-P Receptor-Independent Pathway to the 
Lyric Granules Also Exists 
Although  the I-cells show reduced levels of  granzymes, these 
proteins are still detectable within the cell lysates (Fig.  1). 
The antiserum to granzyme A was used to determine the in- 
tracellular  localization  of this  protein  by immunofluores- 
cence.  As  shown  in  Fig.  2,  this  antiserum  detects  the  27-kD 
monomer and  50-kD  dimer  of  granzyme  A by  immunoblot- 
ring.  The staining  specificity  of  this  antiserum  is  shown in 
Fig.  7, where perrneabilized  COS-7 cells  were transiently 
transfected  with  the  human granzyme  A eDNA in  order  to 
verify the staining specificity of this antiserum. Transfected 
cells stain with the antisera whereas untransfected cells in 
the background do not. The staining pattern indicates that in 
transiently transfected COS-'/cells the majority of the pro- 
tein is in the ER and Golgi region. Fig. 8 demonstrates intra- 
cellular staining with this antisera on permeabilized acti- 
vated  lymphocytes at  4  and  13  d  after  stimulation.  All 
pictures shown in Fig. 8 were taken using the confocal MRC- 
600 microscope (Bio Rad Labs.) under identical settings. By 
13 d after stimulation both normal and I-cells show a punt- 
tare cytoplasmic staining for granzyme A  suggesting that 
even in the I-cells a certain amount of  the granzyme A is cor- 
rectly  localized  within  the  lyric  granules  of  the  cells. 
Quantification of the intensity of staining in the granules for 
each type revealed a mean fluorescence intensity of 133 for 
granules in normal cells, but only 86 for granules in I-cells. 
Taken together with the fact that there are fewer granules per 
cell in I-cells compared with normal cells, this is consistent 
with the biochemical data that show reduced levels of gran- 
zyme A in I-cells. 
The nature of the exact endocytic compartments in which 
granzyme A was detected in the I-cells was further inves- 
tigated by  subcellular  fractionation of normal  and  I-cell 
granules on a Percoll gradient (Fig. 9). Granzyme A activity 
was measured by the enzymatic cleavage of BLT from differ- 
ent fractions of a Percoll density gradient taken from equal 
numbers of  normal and I-cells at 12 d after stimulation. This 
method has been demonstrated to provide a reliable separa- 
tion of the lyric components from other mitochondrial, cyto- 
solic, and plasma membrane markers (Masson et al., 1985; 
Millard et al.,  1984).  In normal cells the majority of the 
granzyme  A activity is found  in the dense granule peak (frac- 
tions  14-18).  A  lower amount of granzyme A  activity is 
found in these same fractions in the I-cells, demonstrating 
that a certain amount of granzyme A can be correctly local- 
ized within the cells to an organelle of the same density as 
Figure  7.  COS-'/ c~lls tran- 
siently  transfected with  hu- 
man granzyme A, stained af- 
mr  permeabilization  with the 
rabbit  anti-granzyme  A  an- 
tiserum  and  an  anti-rabbit 
FITC  antibcxly,  and  pho- 
tographed by con.focal  mi- 
croscopy  using  a 63x  objec- 
tive. Bar, I0/zm. 
The  Journal  of  Cell  Biology,  Volume 120,  1993  890 Figure 8.  Expression of granzyme A in normal (A and B) and I-cell (D and E) T cell clones at different stages after stimulation.  Cells 
were permeabilized  and stained as described  (see Materials  and Methods) at 4 d (A and D) and 13 d (B and E) after stimulation.  The 
same dilution of preimmune  serum was used to stain both normal and I-cells in the negative controls  (C and F,, respectively). 
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Figure 9. Granzyme A activity of different fractions from a Percoll 
density  fractionation  of equal numbers of cells from normal and 
I-ceU cultures at 12 d after stimulation.  1 in 10 dilutions of each 
fraction were made and assayed for granzyme A activity using the 
synthetic substrate BLT as described. A single endpoint reading for 
absorbance at 405 nm was made after 20 min at room temperature. 
The absorbance at 405 nm was read after 20 min and plotted against 
the fraction number. 
the normal lyric granule. However, an equivalent amount of 
the I-cell granzyme A activity appears to be localized within 
a lighter density fraction (fractions 2-5), compared with a 
smaller amount in normal cells. These lighter vesicles could 
possibly correspond to an earlier stage in the biogenesis of 
the lytic granule or smaller vesicles in the constitutive secre- 
tory pathway. 
These results indicate that, despite the fact that I-eel  ! lym- 
phocytes secrete granzymes A  and  B,  a  small amount of 
these granzymes is able to be correctly localized in the lyric 
granules.  One possibility is  that the lytic granule compo- 
nents  in  the  I-cells  are  taken  up  exogenously  from  the 
medium. To be sure that the granzyme A  activity detected 
represented endogenous granzyme and not exogenous pro- 
tein taken up via the endocytic pathway, the cells were grown 
in the presence or absence of 5 mM Man-6-P. Normal cells 
grown in the presence of 5 mM Man-6-P showed a level of 
granzyme A activity (54 mU/mg) slightly below that of nor- 
mal cells grown in the absence of Man-6-P (64 mU/mg). 
I-cells  exhibited  lower  specific  activities  of granzyme  A 
compared with normal cells and this activity was not affected 
by the presence (20 mU/mg) or absence (19 mU/mg) of Man- 
6-P.  This indicates  that granzyme A  is reaching the  lyric 
granules of I-cells from the biosynthetic and not the endo- 
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granzyme A and cathepsin B 
in (,4) normal and (B) I-ceU 
granules. Cells were permea- 
bilized and stained for gran- 
zyme  A and cathepsin I3 as de- 
scribed  (see  Materials  and 
Methods), and examined  using 
the MRC-600 confocal micro- 
scope with the Krypton Argon 
laser. Signals from fluorescein 
detecting granzyme A (righO 
and  Texas  red  detecting 
cathcpsin  B  (left) are  dis- 
played simultaneously for the 
same group of cells. 
cytic Man-6-P receptor route. Although the possibility that 
external granzyme A  is being internalized via a Man-6-P- 
independent pathway cannot be excluded, the data are con- 
sistent with the idea that a  Man-6-P receptor-independent 
pathway to the lytic granules also exists in these cells. 
Lyric  granules  are  known  to  co-stain  with  lysosomal 
markers  such as  the cathepsins  (Bonifacino et al.,  1989; 
Burkhardt et al.,  1990; Peters et al.,  1989). Lyric granules 
co-stain with cathepsin B in both the normal and I-cells (Fig. 
10). All granzyme A structures stain with cathepsin B, and 
all cathepsin B structures stain with granzyme A in both cell 
types, indicating a complete overlap of lyric and lysosomal 
compartments in the lymphocytes at 13 d after stimulation 
in both 1-cells and normal cells. (This overlap can be verified 
by overlaying all pixels from the fluorescein and Texas red 
channels using  the "merge" program on the Bio-Rad 600 
confocal microscope.) This indicates that in lymphocytes the 
Man-6-P receptor-independent pathway is utilized by both 
lysosomal and lyric granule components. 
1-CeU Cytotoxicity is Not Impaired 
To determine whether regulated secretion of the I-cell gran- 
ules could occur, the ability of I-cells to lyse targets was ex- 
amined.  Target cell lysis by normal and I-cell CD8  § lym- 
phocytes was  compared.  To  equalize  the  strength  of the 
signal triggering the two types of T cells to kill, the target 
cells were coated with an antibody to the CD3 molecule in 
the T-cell receptor complex, which is identical in all T cells 
(unlike the variable, antigen-T cell receptor). Cross-linking 
of this receptor triggers T cells to release their lytic granules 
and kill the targets contacted (Lanzavecchia et al., 1988). By 
examining the degree of cell lysis of the targets at different 
effector (T cell)-to-target ratios it is possible to assess the 
effectiveness of the killer cells. Fig.  11 plots the amount of 
target cell lysis at different effector-to-target cell ratios for 
T cells at 14 d after activation. The cytotoxicity  of the I-cells 
is not impaired and even at a  1:1 ratio these cells can lyse 
40% of the target cells. These results are consistent with the 
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Figure 11.  The percentage  of specific target cell lysis of normal 
versus I-cells after a 4-h incubation of P815 targets coated with anti- 
CD3 antibody plotted against different effector-to-target (E/T) ra- 
tios used. Cytolytic lymphocytes were assayed at 14 d after stimu- 
lation. 
idea that some of the lytic proteins are correctly localized in 
lytic granules within the I-cells, and that these granules can 
be exocytosed by triggering via the T cell receptor complex 
as in a normal cytolytic T  cell. 
Discussion 
The results presented here demonstrate that granzymes A 
and B can be targeted to the specialized lyric granules  of 
cytolytic lymphocytes by two different mechanisms. The ma- 
jor mechanism involves recognition by the Man-6-P recep- 
tor.  However, the  present  results  suggest that  a  Man-6-P 
receptor-independent  pathway also exists. 
The Man-6-P receptor pathway has been well character- 
ized as the lysosomal sorting pathway for soluble lysosomal 
proteins  (Kornfeld,  1990).  Proteins  destined  for the lyso- 
some are selectively recognized by the phosphotransferase 
responsible for addition of Man-6-P during glycosylation. 
These proteins are recognized by the Man-6-P receptor in 
the Golgi  apparatus  and  shuttled  to the lysosome by this 
receptor￿9 In  I-cells the phosphotransferase  is  defective or 
missing and, consequently, ceils are unable to add the Man- 
6-P  oligosaccharide  during  processing  and the  lysosomal 
proteins cannot be recognized by the Man-6-P receptor. In 
these cells,  lysosomal proteins  are constitutively  secreted 
(Neufeld et al.,  1975)￿9 
Studies  on  the  lytic  granules  which  demonstrated  the 
colocalization of lysosomal and lyric markers  in cytolytic 
cells (Bonifacino et al., 1989; Burkhardt et al., 1989; Peters 
et al.,  1991),  and the phosphorylation of one of the gran- 
zymes in a rat cell line (Burkhardt et al.,  1989) led to the 
suggestion that the granzyme might be targeted to the lyric 
granules by the lysosomal pathway. By deriving T cell clones 
from a patient with I-cell disease it was possible to test the 
hypothesis that granzymes A and B are targeted to the lyric 
granules of these cells by the Man-6-P receptor. The finding 
that  granzymes  A  and  B  are  secreted  from  lymphocyte 
clones derived from a patient with I-cell disease suggests that 
these proteins are behaving exactly like soluble lysosomal 
proteins and that their targeting normally relies upon the rec- 
ognition ofa Man-6-P. It is known from the cDNA sequences 
of these proteins  that  they contain  potential  glycosylation 
sites.  Granzyme  A,  which  forms  a  dimer,  contains  one 
glycosylarion site per  chain  and granzyme  B, which is a 
monomer, contains two glycosylation sites (Gershenfeld et 
al.,  1988; Schmid and Weissmann,  1987). According to the 
data presented in this paper, the single granzyme A site and 
at least one of the carbohydrate structures of granzyme B 
must be modified with a Man-6-P. In the case of granzyme 
A,  direct biochemical evidence of a phosphate-containing 
oligosaccharide side chain is shown (Fig.  6).  This data is 
consistent with previous studies on a rat natural  killer cell 
line, RNK-16, which also demonstrated a phosphate-labeled 
Endo H-sensitive granzyme in these cells (Burkhardt et al., 
1989). 
The fact that granzyme B is differently processed in nor- 
mal and I-cells supports the idea that Man-6-P is also nor- 
mally added to this protein during processing,  and that in 
I-ceUs the Man-6-P modification is not possible. However, 
as previously noted in fibroblasts (Hasilik and yon Figura, 
1981),  the glycosylation site can still be modified by other 
side chains.  In  the case of granzyme  B,  this  results  in  a 
glycosylated protein with a higher molecular weight, which 
becomes Endo H resistant, indicating that the protein has ac- 
quired complex carbohydrate structures. The fact that treat- 
ment with  PNGase F,  which removes all of the carbohy- 
drates, reduces both the I-cell and normal cell granzyme B 
to the same size protein supports this conclusion. This differ- 
ence in processing is also important as it demonstrates that 
the phosphotransferase defect is complete in the I-cell lines 
derived. Since any granzyme B which was modified with a 
Man-6-P  would remain  Endo  H  sensitive,  the absence of 
Endo H-sensitive forms of granzyme B in the I-cell lysate 
demonstrates the absence of detectable phosphotransferase 
activity  in  these  cells.  All  three  forms  of granzyme  B 
identified by immunoblotting in the I-cell lysate (30, 32, and 
35 kD) remain resistant to Endo H treatment (Fig. 5) demon- 
strafing that all three intermediate  forms possess complex 
sugars. 
Granzymes A and B are soluble lyric granule components 
and the data demonstrate that they can be targeted to the lytic 
granules  by  the  same  mechanism  used  to  target  soluble 
lysosomal proteins to lysosomes. Membrane-bound compo- 
nents of the lyric granules also appear to reach the lytie gran- 
ules via a lysosomal targeting system: a recently identified 
protein, TIA-1, which can induce DNA fragmentation in tar- 
get cells,  has been found to contain  the carboxy-terminal 
lysosomai targeting motif (Tian et al.,  1991) responsible for 
directing  membrane-bound  lysosomal  proteins  such  as 
lamp-1  and lgp 120 (Chert et al.,  1988; Howe et al.,  1988) 
to the lysosomes. The finding  that the lyric granules  use 
lysosomal targeting mechanisms to target their lyric proteins 
to the lyric granules  strongly  supports the idea that these 
granules are modified lysosomes. There is a great deal of evi- 
dence in favor of this view. Lysosomal proteins are released 
during cell-mediated killing (Zucker et al.,  1983) and, fur- 
thermore,  a correlation between the presence of lysosomal 
proteins and killing in natural killer ceils, which also contain 
lyric granules,  has  been noted  (Shau  and Dawson,  1984, 
1985). Several studies have demonstrated the colocalization 
of lysosomal and lyric proteins and the fact that both can be 
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(Bonifacino  et al.,  1989; Burkhardt et ai.,  1990; Peters et 
al.,  1991). Furthermore, EM studies have shown that lyric 
granules with a pH-sensitive tracer have an acidic pH of 5.5 
(Burkhardt et al., 1990; Masson et al., 1990) similar to that 
of prelysosomes or lysosomes. 
Two important features distinguish the lyric granules from 
lysosomes: (/) only the lyric granules contain lyric proteins, 
and (2) these lytic granules  are secretory storage granules 
that can be released upon stimulation  of the cell. Cytolyric 
lymphocytes only develop lyric granules after activation and 
it is not clear whether these are preexisting organelles which 
become filled  by the newly synthesized  lyric  proteins  or 
whether the lyric  granules  are newly derived organeUes. 
However, as a result of T cell activation, a new organdie (the 
lyric granule)  containing  both lysosomal and lyric proteins 
appears, and this organdie can be exocytosed in response to 
signaling via the T cell receptor complex. In general, lyso- 
somes do not undergo exocytosis, although exceptions have 
been described. Several studies have reported the constitu- 
tive secretion of lysosomal enzymes from different cell lines. 
Macrophages,  which are phagocytic cells of the immune sys- 
tem, secrete lysosomal enzymes independently  of external 
stimuli  (Schnyder  and  Baggiolini,  1978).  In  osteoclasts, 
lysosomal enzymes are also constitutively  secreted and the 
colocaiizarion  of the cation-independent  Man-6-P receptor 
with the lysosomal proteins along the exocytic pathway im- 
plies that this receptor is involved in the secretion of these 
proteins ~aron et al., 1988). There are also a few examples 
of regulated  secretion  of lysosomal  enzymes:  polymor- 
phonuclear leukocytes, which are involved in the inflamma- 
tory responses of the immune system, store lysosomal pro- 
teins  in  azurophilic  granules  which  are  released during 
phagocytosis by these cells (Bretz  and Baggiolini,  1974). 
Cathepsin  B has  also been shown  to be secreted via the 
regulatory secretory pathway in rat exocrine pancreatic  ceils 
(Tooze et ai.,  1991), although  it is not clear whether the 
Man-6-P receptor is involved in this trafficking. 
The secretion of lysosomal enzymes is unusual, but illus- 
trates that the sorting of lysosomal from secretory proteins 
need not be absolute in every cell type. Furthermore,  the 
sorting  between the  regulated  and  constitutive  secretory 
pathways can vary for a given protein.  There are now several 
examples of proteins that, under different physiological con- 
ditions,  can be secreted by both regulated  and constitutive 
routes.  For example,  in lactating  mammary epithelial  ceils 
caseins and other milk proteins can be secreted not only con- 
stitutively but also via a calcium-dependent  regulatory path- 
way in response to ionomycin (Turner et al., 1992). In con- 
verse, proteins normally secreted via the regulatory pathway 
can be secreted constitutively  under conditions of hyper- 
stimulation,  as has been demonstrated for insulin  released 
from immature granules of pancreatic cells (Aryan et al., 
1991). These examples suggest that the segregation between 
the constitutive,  regulatory,  and lysosomal routes occurring 
in the trans-Golgi network (Griffiths and Simons,  1986; Orci 
et al., 1987; Tooze et al., 1989) may not be rigid for a given 
protein and that the route taken may vary. This is certainly 
the case in the activated cytolytic cell where both lysosomal 
and secretory proteins are targeted to the same compart- 
ment. In activated cytolytic cells, it appears that the positive 
lysosomal sorting  signal (Man-6-P recognition)  can be uti- 
lized to direct lyric proteins to a lysosomai structure which 
is  nevertheless  a  regulatory  secretory organelle.  Exactly 
where and indeed whether the lyric granule diverges from a 
lysosome during biogenesis in order to become a regulatory 
secretory organdie is still unclear. From the present results 
it is not possible to distinguish between the possibilities  that 
these lysosomal and regulatory secretory proteins fail to sep- 
arate in the TGN, or that they separate in the TGN and merge 
in a later endocytic compartment. 
The data provide evidence for two mechanisms for sorting 
granzymes to the lytic granules, one of which is the Man-6-P 
receptor sorting  signal used for sorting  soluble proteins to 
lysosomes. However, even when the Man-6-P receptor path- 
way is inoperable, as it is in I-cells,  the reduced levels of 
granzymes retained within the cells are nevertheless  cor- 
rectly localized.  Therefore,  an alternative  Mand~-P recep- 
tor-independent pathway to the lyric granules must also ex- 
ist. This alternative route appears to be less efficient than the 
Man-6-P  receptor-mediated  sorting  since I-cells contain 
only 20% or less of the granzyme A and B levels of normal 
cells by day 14 after stimulation  (Fig.  1). 
Interestingly,  cathepsin  B is also able to reach the lyric 
granules  in the I-cells,  suggesting  that  a  Man-6-P recep- 
tor-independent  pathway  also exists  for these proteins  in 
cytolytic lymphocytes. It is important to note that there is no 
evidence for this Man-6-P receptor-independent pathway in 
the majority of other cell types (Kornfeld,  1990). The ques- 
tion of whether such a route exists for lysosomai enzymes 
was raised some time ago in reports that noted nearly normal 
levels of lysosomal enzymes in certain cell types from I-cell 
patients including hepatoc-ytes and lymphocytes (Owada and 
Neufeld, 1982; Waheed et al.,  1982). These data were de- 
rived from whole tissues  and it was not clear whether the 
cells were able to increase their enzyme levels by means of 
very efficient endocytosis or whether the newly synthesized 
enzymes were directed to the lysosomes by an alternative 
signal. In a recent report (Rijnboutt et al., 1991), it has been 
demonstrated that in hepatocytes the unglycosylated form of 
cathepsin  D, produced by growing the cells in the presence 
of tunicamycin, could be correctly transported to lysosomes. 
The authors were able to demonstrate a transient  membrane 
association of procathepsin  D in an intermediate endosomal 
compartment  before the  lysosome,  suggesting  a  specific 
Man-6-P receptor-independent sorting association.  The fact 
that an alternative  pathway exists in cytolytic lymphocytes 
not only for the lyric proteins but also for the lysosomal en- 
zymes raises the possibility that the lysosomal and regulated 
secretory pathways are merged in these cells. The exact na- 
ture of the regulated secretory sorting  signal is not known, 
but sorting seems to involve a selective aggregation  of the 
secretory proteins in the trans-Golgi  network (Huttner and 
Tooze,  1989).  Whether such an aggregation  occurs in the 
formation of lyric granules is not known. 
The regulated secretion of lyric proteins by cytolytic cells 
can be detected by the ability of these cells to lyse targets. 
Both normal and I-cells lyse target cells, indicating that regu- 
lated secretion of the lyric granules  is similar  in these two 
cell types (Fig.  11). These results agree with earlier studies 
which demonstrated normal levels of natural killer cell activ- 
ity in I-cell patients  (Haubeck et al.,  1985).  Although  the 
constitutive  secretion  of granzymes from activated  I-cells 
cells might be expected to have deleterious effects and lead 
The Journal of Cell Biology, Volume 120,  1993  894 to nonspecific target cell destruction,  this is unlikely  since 
it has been demonstrated that both direct cell contact and T 
cell receptor  stimulation  are required  for killing  to occur 
(Lanzavecchia,  1986).  This would explain why I-cell pa- 
tients appear to have normal cytotoxic responses. 
The lytic  granules  are  specialized  secretory organdies, 
produced upon T cell activation.  Morphologically they ap- 
pear  to be a cross between a  lysosome and a  regulatory 
secretory  granule  (Burkhardt et  al.,  1989;  Peters  et al., 
1991). Furthermore, the lyric proteins can be sorted to these 
secretory  granules by virtue of lysosomal targeting signals. 
This  strengthens  the idea that the biogenesis of these or- 
ganelles is related. Conventional lysosomes are rarely found 
in activated cytolytic lymphocytes as demonstrated  by Fig. 
I0,  which  shows  that  all  endocytic  vesicles  containing 
cathepsin B also contain granzyme A. This suggests that the 
lyric granules perform both lysosomal and secretory roles in 
the activated T cell. 
G. M. Griffiths would like to thank Drs. W. Schuler, K. yon Figura, A. 
Kohlschutter, and O. Classen for their assistance in obtaining I-cell periph- 
eral blood, and Drs. A. Lanzavecchia and P. Panina-Bordignon for teach- 
ing me the art of in vitro human T cell culture and providing normal T cell 
clones. Dr. J. Tschopp generously provided antiserum to granzyme B and 
many helpful discussions. Dr. Dan Denney provided the SRt~ transfection 
vector that works so well. Many members of the Department of  Biochemis- 
try at the University of  Basel made many helpful suggestions, but in partic- 
ular Drs. I. Geffen and M. Speiss should be thanked for many discussions 
and meticulous reading of the manuscript at different stages. I would like 
to thank Drs. Y. Argon, K. Karajalainen, J. Kaufman, and A. Lanzavec- 
chin for critical reading of the manuscript and Ben Pfeiffer for invaluable 
photographic assistance. 
The Basel Institute for Immunology was founded and is supported by 
Hoffmarm-LaRoche, Basel, Switzerland. 
Received for publication on 10 August 1992 and in revised form 9 Novem- 
ber 1992. 
References 
Aryan, P., R. Knliawat,  D. Prabakaran,  A. M. Zavacki,  D. Elahi, S. Wang, 
and D. Pilkey.  1991. Protein discharge from immature  secretory grannies 
displays both regulated  and constitutive  characteristics.  3'.  Biol.  Chem. 
266:14171-14174. 
Balch, W. E., and J. E. Rothman.  1985. Characterization  of protein transport 
between successive  compartments of the Golgi apparatus:  asymmetric prop- 
erties of donor and acceptor activities in a cell-free system. Arch. Biochem. 
Biophys.  240:413-425. 
Baron, R., L. Neff, W. Brown, P. J. Conrtoy, D. Louvard,  and M. G. Farqu- 
bar.  1988. Polarized secretion of lysosomal  enzymes: co-distribution  of 
cation-independent  mannose-6-pbosphate  receptors and lysosomal enzymes 
along the osteoclast exocytic pathway. J.  Cell Biol.  106:1863-1872. 
Bonifacino, J. S., L. Yuan, and I. V. Sandoval.  1989. Internalization and recy- 
cling to serotonin-containing  granules of  the 80K integral membrane protein 
exposed on the snrface of secreting rat basophilie ieukaemia cells. Z  Cell 
Sci.  92:701-712, 
Bretz, U., and M. Baggiolini.  1974. Biochemical and morphological character- 
ization of azurophil  and specific granules  of human nentrophflic  polymor- 
phonnclear leukocytes.  J.  Cell BioL  63:251-269. 
Burkhardt,  J. K., S. Hester, and Y. Argon. 1989. Two proteins targeted to the 
same lyric granule compartment undergo very different  posttranslational pro- 
cessing. Proc. Natl. Acad. Sci.  USA.  86:7128-7132. 
Bnrkhardt,  J. K., S. Hester, C. K. Lapham, and Y. Argon. 1990. The lyric 
granules of natural killer cells are dual-function organdies combining secre- 
tory and pre-lysosomal compartments. J.  Cell Biol.  111:2327-2340. 
Chen, J. W., Y. Cha, K. U. Yuskel,  R. W. Gracy, and J, T. August.  1988, 
Isolation and sequencing of a cDNA clone encoding lysosomal membrane 
glycoprotein mouse LAMP-1. J.  Biol.  Chem.  263:8754-8758. 
Gershenfeld, H. K., R. J. Hershherger, T. B. Shows, and I. L. Weissman. 
1988. Cloning and chromosomal assignment of a human cDNA encoding a 
T cell- and natural killer cell-specific trypsin-like serine  protease. Proc. Natl. 
Acad.  Sr  USA.  85:1184-1188. 
Glaser, J. H., W. H. McAlister, and W. S. Sly.  1974, Genetic heterogeneity 
in multiple  lysosomal hydrolase deficiency. J.  Pedtatr. 85:192-198. 
Grilfiths, G., and K. Simons. 1986. The trans Golgi network: sorting at the exit 
site of the Gotgi complex.  Science (Wash.  DC). 234:438--443. 
Guan, J. L., and J. K. Rose. 1984. Conversion of a secretory protein into a 
transmembrane protein resnlts in its transport to the Golgi complex but not 
to the cell surface. Cell.  37:779-787. 
Hameed, A., D. M. Lowrey, M. Lichtenheld, and E. R. Podack. 1988. Charac- 
terization of three serine esterases isolated from human IL-2 activated killer 
cells. J. lmmunol.  141:3142-3147. 
Harlow,  E.,  and D.  Lane.  1988. Antibodies:  A  Laboratory  Manual.  Cold 
Spring Harbor Laboratory, Cold Spring Harbor, NY. 341. 
Hasilik, A., and K. yon Figura. 1981. Oligosaccharides in lysosomal enzymes. 
Distribution  of high-mannose and complex oligosaccharides  in cathepsin D 
and beta-hexosaminidase.  Eur. J. Biochem.  121:125-129. 
Haubeck,  H. D., E. Kolsch, M. Imort, A. Hasilik,  and K. yon Figura. 1985. 
Natural killer cell-mediated cytotoxicity does not depend on recognition of 
mannose 6-phosphate  residues. J. Immunol.  134:65-69. 
Henkart, P. A., P. J. Millard, C. W. Reynolds, andM. P. Henkart.  1984. Cyto- 
lytic activity of purified cytoplasmic grannies from cytotoxic rat large granu- 
lar lymphocyte tumors. J. Exp.  Med.  160:75-93. 
Howe, C. L., G. B. L., M. Hull, S. A. Green, C. A. Gabel, A. Helenius,  and 
I. Mellman.  1988. Derived protein sequence, oligosaccharides,  and mem- 
brane insertion of the 120-kD lysosomal membrane glycoprotein (lgp 120): 
identification of  a highly conserved family oflysosomal  membrane glycopro- 
teins. Proc. Natl. Acad.  Sci.  USA.  85:7577-758I. 
Huttner,  W. B., and S. A. Tooze. 1989. Biosynthetic protein transport in the 
secretory pathway.  Curr.  Opin.  Cell Biol.  1:648-654. 
Komfeld, R., and S. Kornfeld.  1985. Assembly of asparagine-linked  oligosac- 
charities.  Annu. Rev.  Biochem.  54:631-664. 
Kornfeld, S.  1990. Lysosomal  enzyme targeting.  Biochem.  Soc.  Trans.  18: 
367-374. 
Krahenbuhl, O., C. Rey, D. Jenne, A. Lanzavecchia,  P. Groscurth, S. Carrel, 
and J. Tschopp. 1988. Characterization  of granzymes A and B isolated from 
granules  of  cloned  human  cytotoxic  T  lymphocytes.  J.  ImmunoL 
141:3471-3477. 
Lanzavecchia, A. 1985. Antigen-specific interaction between T and B ceils. Na- 
ture (Lond.).  314:537-539. 
Lanzavecchia, A. 1986. Is the T-cell receptor involved in T-cell killing? Nature 
(Lond.).  319:778-780. 
Lanzavecchia,  A., S. Abrignani, D. Scheidegger, R. Obrist, B. Dorken, and 
G. Moldanhauer.  1988. Antibodies as antigens. The use of mouse monoclo- 
nal antibodies to focus human T cells against selected targets. Z  Exp.  Med. 
167:345-352. 
Little,  L., M. Alcoulomore, A. M. Drotar,  S. Herman, R. Robertson, R. Y. 
Yeh, and A. L. Miller. 1987. Properties of N-acetylglucosamine  1-phospho- 
transferase from human lymphoblasts.  Biochem.  J. 248:151-159. 
Masson, D., and J. Tschopp. 1987. A family of  serine esterases in lyric granules 
of cytolytic  T lymphocytes.  Cell.  49:679-4585. 
Masson, D., P. Corthesy, M. NabboLz, and J. Tschopp. 1985. Appearance of 
cytolytic granules upon  induction  of cytolytic  activity  in  CTL-hybrids. 
EMBO (Fur.  Mol.  Biol.  Organ.) J. 4:2533-2538. 
Masson, D., P. J. Peters, H. J. Geuze, J. Borst, and J. Tschopp.  1990. Interac- 
tion of chondroitin snlfate with perforin and granzymes of cytolytic T-cells 
is dependent on pH. Biochemistry.  29:11229-11235. 
Millard,  P. J., M. P. Henkart,  C. W. Reynolds, and P. A. Henkart.  1984. 
Purification and properties of cytoplasmic granules from cytotoxic rat LGL 
tumors. J. lmmunoL  132:3197-3204. 
Nenfeld,  E. F., T. W. Lim, and L. J. Shapiro.  1975. Inherited disorders of 
lysosomal metabolism.  Annu~ Rev. Biochem. 44:357-376. 
Odake, S., C. M. Kam, L. Narasirahan,  M. Poe, J. T. Blake, O. Krahenbuhl, 
J. Tschopp, and J. C. Powers. 1991. Hnman and murine cytotoxic T lympho- 
cyte serine proteases: subsite mapping with peptide thioester substrates and 
inhibition of enzyme activity and cytolysis by isocoumarins.  Biochemistry. 
30:2217-2227. 
Okayama, H., and P. Berg. 1983. A eDNA cloning vector that permits expres- 
sion of eDNA inserts in mammalian  ceils. Mol.  Cell.  Biol.  3:280-289. 
Orci, L., M. Ravazzola, M. J. Storch, R. G. Anderson, J. D. Vassalli, and A. 
Perrelet. 1987. Proteolytic maturation of insulin is a post-Golgi event which 
occurs in acidifying clathrin-coated  secretory vesicles. Cell.  49:865-868. 
Owada, M., and E. F. Neufeld.  1982. Is there a mechanism for introducing acid 
hydrolases into liver lysosomes that is independent of mannose 6-pbosphate 
recognition?  Evidence  from I-cell disease. Biochem.  Biophys.  Res.  Com- 
mun.  105:814-820. 
Pasternaek,  M. S., C. R. Verret, M. A. Liu, and H. N. Eisen. 1986. Serine 
esterase in cytolytic T lymphocytes. Nature (Lond.).  322:740-743. 
Peters, P. J., H. J. Genze, H. A. Van der Donk, J. W. Slot, J. M. Gritfith, 
N. J. Stam,  H. C. Clevers, and J. Borst.  1989. Molecules relevant for T 
cell-target cell interaction are present in cytolytic granules of human T lym- 
phocytes, Fur. J.  Immunol.  19:1469-1475. 
Peters, P. J., J. Borst, V. Oorschot, M. Fukuda,  O. Krahenhuhl,  J. Tschopp, 
J. W. Slot, and H. J. Genze. 1991. Cytotoxic T lymphocyte granules  are 
secretory lysosomes, containing both perforin and granzymes. J. Exp. Med. 
173:1099-1109. 
Podack, E. R., and P. J. Konigsberg. 1984. Cytolytic T cell granules. Isolation, 
structural,  biochemical,  and  functional  characterization.  J.  Exp.  &led. 
160:695-710. 
Podack, E. R., and A. Knpfer. 1991. T-cell effector functions: mechanisms for 
Grifliths and Isaaz Man-6-P Receptor Targeting  of Granzymes  895 delivery of cytotoxieity and help. Annu. Rev.  Cell Biol.  7:479-504. 
Rijnboutt, S., A. J. Kal, H. J. Geuze, H. Aerts, and G. J. Strous. 1991. Man- 
nose 6-phosphate-independent targeting of cathepsin D  to  lysosomes in 
HepG2 cells. J. Biol. Chem. 266:23586-23592. 
Scalera, V., C. Storelli,  C. Storelli-Joss, H. Haase, and H. Murer.  1980.  A 
simple and fast method for the isolation of basolateral plasma membranes 
from the rat small intestinal epithelial  cells. Biochem../.  186:177-181. 
Sehmid, J., and C. Weissrnarm. 1987. Induction ofmRNA for a serine protease 
and a beta-thromboglobulin-like  protein in mitogen-stimulated  human  leuko- 
cytes. J. Immunol.  139:250-256. 
Schnyder, J., and M. Baggiolini. 1978.  Secretion of lysosomal hydrolases by 
stimulated and nonstimulated macrophages. J.  Exp. Med. 148:435-450. 
Shau, H., and J. R. Dawson. 1984. The role of the lysosome in natural killing: 
inhibition by lysosomotropic vital dyes. Immunology.  53:745-751. 
Shau, H., and J. R. Dawson. 1985. Identification  and purification  of NK cells 
with lysosomotropie vital stains: correlation of lysosome content with NK 
activity. J.  lmmunol.  135:137-140. 
Takebe, Y., M. Seiki, L  Fujisawa, P. Hoy, K. Yokota, K. Arai, M. Yoshida, 
and N. Arai. 1988. SR alpha promoter: an efficient and versatile mammalian 
eDNA expression system composed of the simian virus 40 early promoter 
and the R-U5 segment of human T-cell leukemia virus type 1 long terminal 
repeat. Mol.  Cell. BioL 8:466--472. 
Tian, Q., M. Streuli,  H. Saito,  S. F. Schlossman, and P, Anderson. 1991. A 
potyadenylate binding protein localized to the granules of cytolytic lympho- 
cytes induces DNA fragmentation in target ceils. Cell. 67:629-639. 
Tooze, J., H. F. Kern, S. D. Fuller, and K. E. Howell. 1989. Condensation- 
sorting events in the rough endoplasmic reticulum of exocrine pancreatic 
cells..L  Cell Biol. 109:35-50. 
Tooze, J., M.  Holliushead, G. Hensel, H. F. Kern, and B. Hoflack.  1991. 
Regulated secretion of mature cathepsin B from rat exocrine pancreatic cells. 
Eur. J.  Cell Biol.  56:187-200. 
Tschopp, J., and M. Nabholz. 1990. Perforin-mediated target cell lysis by cyto- 
lytic T lymphecytes. Annu. Rev.  lmmunoL  8:279-302. 
Turner, M. D., M. E. Rennison, S. E. Handel, C. J. Wilde, and R. D. Bur- 
goyne~ 1992. Proteins are secreted by both constitutive and regulated secre- 
tory pathways in lactating  mouse mammary epithelial  cells. J.  Cell Biol. 
t 17:269-278. 
yon Figura, K., and A. Hasilik. 1986. Lysosomal  enzymes and their receptors. 
Annu.  Rev. Biochem.  55:167-193. 
Waheed, A., R. Pohlmann, A. Hasilik, K. yon Figura, A. van Elsen, and 
J. G. Leroy. 1982. Deficiency  of UDP-N-acetylglucosamine:lysosomal  en- 
zyme N-acetylglucosamine-l-phosphotransferase  in organs  of I-cell patients. 
Biochem. Biophys.  Res.  Commun.  105:1052-1058. 
Zueker, F, D., G. Grusky, and L S. Yang. 1983. Arylsulfatase  in natural killer 
cells: its possible role in cytotoxicity. Proc. Natl. Acad. Sci. USA. 80:6977- 
6981. 
The Journal of Cell Biology, Volume 120,  1993  896 